user avatar
James Good
@drjamesgood
Oncologist | Husband, father | Englishman | Civilisation enjoyer
Oxford, Birmingham and London
doctify.com/uk/specialist/…
Joined July 2018
1,655
Following
1,751
Followers
Posts
  • Pinned
    user avatar
    James Good
    @drjamesgood
    Jun 29, 2025
    🧠 This chart popped up in my feed via @balajis It shows the exponential growth in human brain size and complexity over evolutionary time. It got me thinking about oncology. Cancer medicine now sits at the convergence of: 🧬 Biological complexity 🙏 Moral gravity 🚀
    20K
  • user avatar
    James Good
    @drjamesgood
    May 20, 2020
    The beautiful but deserted @unibirmingham campus this morning
  • user avatar
    James Good
    @drjamesgood
    Apr 12, 2020
    As a cancer specialist, this is one of my greatest concerns: cancer death rates due to #COVIDー19 could outstrip viral deaths. We urgently need a safe route out of #lockdown so that #NHS staff can go back to caring for #cancer patients.
    Cancer deaths set to soar amid coronavirus crisis
    From express.co.uk
  • user avatar
    James Good
    @drjamesgood
    Apr 16, 2020
    This is shocking - a tsunami of undiagnosed #cancer is building up in the community that will really stretch #NHS departments once lockdown is lifted - patients will present with more advanced disease needing intensive #radiotherapy and other treatments ⁦@ActionRTherapy⁩
  • user avatar
    James Good
    @drjamesgood
    May 18, 2020
    Now that’s what I call precision radiotherapy - a patient with a solitary liver met being treated at ⁦@GenesisCare⁩ with MR-guided #SABR. An entirely non-invasive, ablative option in the #COVID19 era. ⁦⁦⁦@viewray⁩ ⁦@ActionRTherapy⁩ ⁦@OncoAlert⁩
    00:00
  • user avatar
    James Good
    @drjamesgood
    Nov 5, 2023
    Without a quick and comprehensive resolution, the #MRIdian platform will disappear. Patients will miss out, and technical innovation in radiotherapy will be derailed. But we will not go quietly into that good night… read our open letter to the #radonc community👍
    47K
  • user avatar
    James Good
    @drjamesgood
    Nov 9, 2021
    It’s been a long road but what a great result: #SABR for pancreatic cancer will be made available to NHS patients. bit.ly/3qpugYW — efforts now focus on training, trials, boosting access to MR-guidance, and refining protocols @RTTQA_UK @AliStunt @ActionRTherapy
  • user avatar
    James Good
    @drjamesgood
    Sep 1, 2020
    First #NHS patient to undergo MR-guided #SABR for pancreatic cancer starts treatment next week— 40 Gy in 5# with online adaptation of every fraction. Details: bit.ly/32LAIMn @GenesisCare @PanCanResearch @The_OIRO @viewray @ActionRTherapy @AliStunt @OfficialPCA
  • user avatar
    James Good
    @drjamesgood
    Nov 17, 2023
    This is big— one of the first randomised studies to show a significant improvement in outcome after metastasis-directed therapy in GI cancer, which has been under-represented in previous trials 💥 @OwczarczykKasia @lauren_henke @MikeChuongMD
    user avatar
    The Lancet Gastroenterology & Hepatology
    @LancetGastroHep
    Nov 17, 2023
    New research - Liu et al - Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial thelancet.com/journals/langa… #GITwitter #OncTwitter @OncoAlert
    13K
  • user avatar
    James Good
    @drjamesgood
    Jul 18, 2019
    When even the Friday night bottle🍷 reminds you of #radonc — cheers @AitkenKatharine @DrDThomson @DrewMoghanaki
  • user avatar
    James Good
    @drjamesgood
    Jun 21, 2022
    Randomised confirmation that #SABR gives better tumour control than TACE in #HCC - yet OS is similar - time for comprehensive studies combining radiation ☢️ with immunotherapy 💉 across the BCLC algorithm @UHB_HPB @stef_corradini @MikeChuongMD @andygaya
    user avatar
    NonsparseOncologist
    @5_utr
    Jun 20, 2022
    TRENDY: RCT of TACE vs. SBRT for HCC 👉 HCC, Child-Pugh grade A, one to three tumors, cumulative diameter ≤ 6cm, and ≥ 18 years old. 2 year LC 2x better with SBRT 🤩 😮 #radonc h/t @loladelamata
  • user avatar
    James Good
    @drjamesgood
    Dec 29, 2018
    Replying to @Maherjane
    10 years ago (when I started training) some still folk scoffed that RT would soon become obsolete. No one sensible says that any more, even now in the era of IO. RT is simply a great cancer treatment. Also great advocacy from @NCRI_partners CTRAD, @CR_UK etc has really helped.
  • user avatar
    James Good
    @drjamesgood
    Aug 5, 2020
    The direction of travel is clear! #SBRT is a safe, effective, non-invasive outpatient treatment for #HCC and will play an ever increasing role in management. Potential for MR-guidance particularly exciting. @hccconnectinfo @OncoAlert @GenesisCare @The_OIRO @ldawsonmd
    user avatar
    Journal of Gastroenterology and Hepatology
    @JGHofficial
    Aug 4, 2020
    Review from @MihirShanker et al. outlining the emerging role of SABR in the multidisciplinary mx of #HCC + summarising the latest evidence for its use as an alternative ablative option for early disease, as a bridge to transplant and for palliation. buff.ly/2BLmDFj
  • user avatar
    James Good
    @drjamesgood
    Feb 5, 2022
    I could not disagree more— precision radiation medicine is only just getting started 🚀
    user avatar
    Sunjay Shah
    @sunjay_shah
    Feb 5, 2022
    Replying to @SbrtSean
    Considering that this is the golden age of molecular oncology, why devote the next 30 years to anything other than medical oncology? Surgery and radiation have likely plateaued.